Cadonilimab Antibody
Cadonilimab (AK104) is a humanized bispecific antibody targeting PD-1 and CTLA-4. It modulates T-cell activity by increasing IL-2/IFN-γ and reducing IL-6/IL-8, exhibiting favorable safety and affinity. Its research applications include in vitro immunology assays and in vivo studies for metastatic cervical, gastric, hepatic, lung, pancreatic, and esophageal cancers.
Product Specifications
Product Name Alternative
BTG502
Target
Immunology/Inflammation related, IL Receptor, PD-1/PD-L1, COX
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation, Neuroscience
Concentration
6.91 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
198.64 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
KLF4 (Kruppel-like Factor 4, Kruppel-like Factor 4 (gut) )
ERP44 (Endoplasmic Reticulum Resident Protein ERp44, Thioredoxin Domain Containing 4, PDIA10, TXNDC4) (HRP)
ERP44 (Endoplasmic Reticulum Resident Protein ERp44, Thioredoxin Domain Containing 4, PDIA10, TXNDC4) (HRP)
![MutS Homolog 2 Mouse Monoclonal Antibody [KD Validation]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)